<meta http-equiv="Content-Type" content="text/html; charset=utf-8"><meta name="viewport" content="initial-scale=1"><!--[if (mso)|(mso 16)]>
<style type="text/css">a {text-decoration: none;}</style>
<![endif]--><title>Prognosis</title><table id="wrapper" align="center" border="0" cellpadding="0" cellspacing="0" style="max-width: 550px; padding-top: 10px; width: 100%" width="100%">
<!--[if mso]>
<center>
<tr><td>
<table border="0" cellpadding="0" cellspacing="0" width="550">
<![endif]-->
<tr>
<td style="border-collapse: collapse; mso-table-lspace: 0pt; mso-table-rspace: 0pt">
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tr>
<td style="border-collapse: collapse; mso-table-lspace: 0pt; mso-table-rspace: 0pt">
<table width="100%" border="0" cellspacing="0" cellpadding="0" class="brand-hdr">
<tr>
<td align="center" style="border-collapse: collapse; mso-table-lspace: 0pt; mso-table-rspace: 0pt">
<a href="https://link.mail.bloombergbusiness.com/click/18816595.10615/aHR0cHM6Ly93d3cuYmxvb21iZXJnLmNvbS9wcm9nbm9zaXM/5daec32c52ba1e0621725115B0ead5cdc">
<!--[if mso]>
<table width="550"><tr><td><img alt="Bloomberg" src="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/io0pvKRTT7xk/v0/-1x-1.png" width="550" /></td></tr></table>
<div style="display:none">
<![endif]-->
<img class="logo-image" src="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/io0pvKRTT7xk/v0/-1x-1.png" border="0" alt="Bloomberg" style="width: 100%; max-width: 375px">
<!--[if mso]>
</div>
<![endif]-->
</a>
</td>
</tr>
</table>
</td>
</tr>
<tr>
<td style="border-collapse: collapse; mso-table-lspace: 0pt; mso-table-rspace: 0pt"></td>
</tr>
<tr>
<td style="border-collapse: collapse; mso-table-lspace: 0pt; mso-table-rspace: 0pt; border-top: 1px dotted #000000; padding-bottom: 1px; padding-top: 0"></td>
</tr>
<tr>
<td style="border-collapse: collapse; mso-table-lspace: 0pt; mso-table-rspace: 0pt; border-top: 1px dotted #000000; padding-bottom: 1px; padding-top: 0"></td>
</tr>
<tr>
<td style="border-collapse: collapse; mso-table-lspace: 0pt; mso-table-rspace: 0pt; border-top: 1px dotted #000000; padding-bottom: 1px; padding-top: 0"></td>
</tr>
</table>
<table class="social_component" style="width: 100%" width="100%">
<tr>
<td style="border-collapse: collapse; mso-table-lspace: 0pt; mso-table-rspace: 0pt; padding: 0; padding-top: 9px; padding-bottom: 9px; text-transform: uppercase; font-family: Arial; font-size: 12px; font-weight: normal; font-style: normal; font-stretch: normal; line-height: 1.17; letter-spacing: normal; border-right: 10px solid white; border-top: 1px dotted #000000; border-bottom: 1px dotted #000000"><span style="margin-right: 4px;vertical-align: middle">Follow Us</span> <a href="https://link.mail.bloombergbusiness.com/click/18816595.10615/aHR0cHM6Ly93d3cuZmFjZWJvb2suY29tL2Jsb29tYmVyZ2J1c2luZXNzLw/5daec32c52ba1e0621725115Bc6f3080e" style="text-decoration: none; color: #000"><img src="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iSTidtzUTVno/v0/-1x-1.png" width="20" height="20" style="vertical-align: middle"> </a><a href="https://link.mail.bloombergbusiness.com/click/18816595.10615/aHR0cHM6Ly90d2l0dGVyLmNvbS9idXNpbmVzcw/5daec32c52ba1e0621725115B43b5bf65" style="text-decoration: none; color: #000"><img src="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iD_P6YIGeql4/v0/-1x-1.png" width="20" height="20" style="vertical-align: middle"></a></td>
<td style="border-collapse: collapse; mso-table-lspace: 0pt; mso-table-rspace: 0pt; padding: 0; padding-top: 9px; padding-bottom: 9px; text-transform: uppercase; font-family: Arial; font-size: 12px; font-weight: normal; font-style: normal; font-stretch: normal; line-height: 1.17; letter-spacing: normal; border-left: 10px solid white; border-top: 1px dotted #000000; border-bottom: 1px dotted #000000">
<a href="https://link.mail.bloombergbusiness.com/click/18816595.10615/aHR0cDovL2xpbmsubWFpbC5ibG9vbWJlcmdidXNpbmVzcy5jb20vam9pbi80d20vcHJvZ25vc2lzLXNpZ251cA/5daec32c52ba1e0621725115B63cc86bc" style="text-decoration: none; color: #000">Get the newsletter</a>
</td>
</tr>
</table>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tr>
<td class="body-copy bbiz-wysiwyg-content" style="border-collapse: collapse; mso-table-lspace: 0pt; mso-table-rspace: 0pt; font-family: Helvetica, Arial, sans-serif; font-size: 16px; line-height: 150%; padding: 0 10px">
<p style="font-family: Helvetica, Arial, sans-serif; margin: 1em 0">There are many pastimes that can sooth an anxious mind: meditation, gardening, painting, running. Biotech investing, however, isn't one of them.<br><br>Consider what happened over the span of just a few hours on Thursday. Early in the morning, Sage Therapeutics saw <a href="https://link.mail.bloombergbusiness.com/click/18816595.10615/aHR0cHM6Ly93d3cuYmxvb21iZXJnLmNvbS9uZXdzL2FydGljbGVzLzIwMTktMTItMDUvc2FnZS1zdWZmZXJzLWJsb3ctYXMta2V5LWRlcHJlc3Npb24tc3R1ZHktZmFpbHMtdG8tc2hvdy1iZW5lZml0P2NtcGlkPUJCRDEyMDUxOV9QUk9HJnV0bV9tZWRpdW09ZW1haWwmdXRtX3NvdXJjZT1uZXdzbGV0dGVyJnV0bV90ZXJtPTE5MTIwNSZ1dG1fY2FtcGFpZ249cHJvZ25vc2lz/5daec32c52ba1e0621725115B07923a9b" itemprop="StoryLink" itemscope="itemscope" target="_blank" title="Bloomberg article on Sage shares" style="color: #000000"><meta content="Q21NCOT0AFB9" itemprop="suid"><meta content="StoryLink" itemprop="type">more than half</a> its market value melt away after its experimental treatment for major depressive disorder failed to reach its primary target in a key study. Sage had been a Wall Street sweetheart this year thanks to a run-up in its shares of more than 50%. But its study data <a href="https://link.mail.bloombergbusiness.com/click/18816595.10615/aHR0cHM6Ly93d3cuYmxvb21iZXJnLmNvbS9vcGluaW9uL2FydGljbGVzLzIwMTktMTItMDUvc2FnZS10aGVyYXBldXRpY3MtaW52ZXN0b3JzLWRpbGVtbWEtb24tZmFpbGVkLWNhbmNlci1kcnVnLXRyaWFsP2NtcGlkPUJCRDEyMDUxOV9QUk9HJnV0bV9tZWRpdW09ZW1haWwmdXRtX3NvdXJjZT1uZXdzbGV0dGVyJnV0bV90ZXJtPTE5MTIwNSZ1dG1fY2FtcGFpZ249cHJvZ25vc2lz/5daec32c52ba1e0621725115Ba8c75238" itemprop="StoryLink" itemscope="itemscope" target="_blank" title="Bloomberg Opinion on Sage Therapeutics" style="color: #000000"><meta content="Q21R4D6JIJUR" itemprop="suid"><meta content="StoryLink" itemprop="type">changed the story</a> in the blink of an eye.<br><br>Meanwhile, Acadia Pharmaceuticals was enjoying the sort of upswing that investors dream about. Its shares jumped more than 21% after new data from its antipsychotic drug were better than anticipated in elderly patients with dementia. If the FDA grants the drug a new designation, it could open up a vast new group of patients who currently are treated with older drugs that can come with significant risks.</p>
<p style="font-family: Helvetica, Arial, sans-serif; margin: 1em 0">And then there was Biogen. The biotech giant's year has <a href="https://link.mail.bloombergbusiness.com/click/18816595.10615/aHR0cHM6Ly93d3cuYmxvb21iZXJnLmNvbS9uZXdzL2FydGljbGVzLzIwMTktMTItMDQvaXQtcy1tYWtlLW9yLWJyZWFrLWZvci1hbHpoZWltZXItcy1kcnVnLWluLWJpb2dlbi1kYXRhLXJldmVhbD9jbXBpZD1CQkQxMjA1MTlfUFJPRyZ1dG1fbWVkaXVtPWVtYWlsJnV0bV9zb3VyY2U9bmV3c2xldHRlciZ1dG1fdGVybT0xOTEyMDUmdXRtX2NhbXBhaWduPXByb2dub3Npcw/5daec32c52ba1e0621725115Bdcbf43a7" itemprop="StoryLink" itemscope="itemscope" target="_blank" title="Bloomberg article on Biogen" style="color: #000000"><meta content="Q1ZSDJDWRGH5" itemprop="suid"><meta content="StoryLink" itemprop="type">encapsulated</a> the agony and the ecstasy of investing in innovative medical companies; in March it lost more than a quarter of its market value when it said it was giving up on its aducanumab Alzheimer's therapy. Then it soared in the fall after reviving the treatment -- and the hopes of millions of patients.<br><br>On Thursday, Biogen said at a big meeting of doctors and brain scientists in San Diego that it is <a href="https://link.mail.bloombergbusiness.com/click/18816595.10615/aHR0cHM6Ly93d3cuYmxvb21iZXJnLmNvbS9uZXdzL2FydGljbGVzLzIwMTktMTItMDUvYmlvZ2VuLXJlc3VtZXMtYWx6aGVpbWVyLXMtc3R1ZGllcy10by1vZmZlci1jb250cm92ZXJzaWFsLWRydWc_Y21waWQ9QkJEMTIwNTE5X1BST0cmdXRtX21lZGl1bT1lbWFpbCZ1dG1fc291cmNlPW5ld3NsZXR0ZXImdXRtX3Rlcm09MTkxMjA1JnV0bV9jYW1wYWlnbj1wcm9nbm9zaXM/5daec32c52ba1e0621725115Bde9db5cb" itemprop="StoryLink" itemscope="itemscope" target="_blank" title="Bloomberg article on aducanumab data" style="color: #000000"><meta content="Q21UGRT0G1KW" itemprop="suid"><meta content="StoryLink" itemprop="type">resuming its studies</a> of the drug, and it laid out a previously undisclosed tranche of trial data. That sent its shares up sharply -- after an intraday dip, of course. But big questions remain, including whether regulators might make the company run yet another trial of the medicine. That could add significantly more cost and delay its entry to the market for several more years.</p>
<p style="font-family: Helvetica, Arial, sans-serif; margin: 1em 0">All that excitement in so few hours might have some investors longing to ride their bikes or trim their bonsai trees. But in biotech, any respites are likely to be brief—<a href="mailto:tannett@bloomberg.net" itemprop="StoryLink" itemscope="itemscope" target="_blank" title="Send email to Tim Annett" style="color: #000000"><em>Tim Annett</em></a></p>
<h2 style="line-height: 26px; font-family: Helvetica, Arial Black, Arial, sans-serif; color: #000000; font-weight: bold; margin-top: 5px; margin-bottom: 20px; font-size: 24px">Here's what else we're watching:</h2>
<p style="font-family: Helvetica, Arial, sans-serif; margin: 1em 0"><strong>Global genes</strong>. Foreign drugmakers are <a href="https://link.mail.bloombergbusiness.com/click/18816595.10615/aHR0cHM6Ly93d3cuYmxvb21iZXJnLmNvbS9uZXdzL2FydGljbGVzLzIwMTktMTItMDMvZ2VuZS10aGVyYXB5LW0tYS1hcHBldGl0ZS1wcm92aWRlcy1saWZ0LWFmdGVyLWF1ZGVudGVzLWRlYWw_Y21waWQ9QkJEMTIwNTE5X1BST0cmdXRtX21lZGl1bT1lbWFpbCZ1dG1fc291cmNlPW5ld3NsZXR0ZXImdXRtX3Rlcm09MTkxMjA1JnV0bV9jYW1wYWlnbj1wcm9nbm9zaXM/5daec32c52ba1e0621725115B6bfbbb57" itemprop="StoryLink" itemscope="itemscope" target="_blank" title="Bloomberg article on gene-therapy deals" style="color: #000000"><meta content="Q1Y4NVT0G1L5" itemprop="suid"><meta content="StoryLink" itemprop="type">joining</a> the <a href="https://link.mail.bloombergbusiness.com/click/18816595.10615/aHR0cHM6Ly93d3cuYmxvb21iZXJnLmNvbS9uZXdzL2FydGljbGVzLzIwMTktMTItMDIvYXN0ZWxsYXMtcGhhcm1hLXRvLWJ1eS1hdWRlbnRlcy1pbi0zLWJpbGxpb24tZ2VuZS10aGVyYXB5LWRlYWw_Y21waWQ9QkJEMTIwNTE5X1BST0cmdXRtX21lZGl1bT1lbWFpbCZ1dG1fc291cmNlPW5ld3NsZXR0ZXImdXRtX3Rlcm09MTkxMjA1JnV0bV9jYW1wYWlnbj1wcm9nbm9zaXM/5daec32c52ba1e0621725115B39e41799" itemprop="StoryLink" itemscope="itemscope" target="_blank" title="Bloomberg article on Astellas deal" style="color: #000000"><meta content="Q1XRZTDWRGG3" itemprop="suid"><meta content="StoryLink" itemprop="type">gene-therapy gold rush</a>, as Japan's Astellas agreed to buy U.S.-based Audentes, the maker of a treatment for a life-threatening neuromuscular disease, for $3 billion.</p>
<p style="font-family: Helvetica, Arial, sans-serif; margin: 1em 0"><strong>Carcinogen questions</strong>. Global health regulators are looking into whether the widely used diabetes drug metformin may contain <a href="https://link.mail.bloombergbusiness.com/click/18816595.10615/aHR0cHM6Ly93d3cuYmxvb21iZXJnLmNvbS9uZXdzL2FydGljbGVzLzIwMTktMTItMDQvZGlhYmV0ZXMtZHJ1Z3MtbGF0ZXN0LXRvLWJlLXRhcmdldGVkLWZvci1jYXJjaW5vZ2VuLXNjcnV0aW55P2NtcGlkPUJCRDEyMDUxOV9QUk9HJnV0bV9tZWRpdW09ZW1haWwmdXRtX3NvdXJjZT1uZXdzbGV0dGVyJnV0bV90ZXJtPTE5MTIwNSZ1dG1fY2FtcGFpZ249cHJvZ25vc2lz/5daec32c52ba1e0621725115B7f5fac9b" itemprop="StoryLink" itemscope="itemscope" target="_blank" title="Bloomberg article on metformin" style="color: #000000"><meta content="Q20BAFT0AFB4" itemprop="suid"><meta content="StoryLink" itemprop="type">unsafe levels</a> of a carcinogen previously been found in heart and gastric medications.</p>
<p style="font-family: Helvetica, Arial, sans-serif; margin: 1em 0"><strong>Optimizing Optum.</strong> UnitedHealth is best known for its giant insurance business, but the company said this week it expects Optum, which houses its PBM and physician practices, will soon make up about half its profits.</p>
<p style="font-family: Helvetica, Arial, sans-serif; margin: 1em 0"><strong>Listen up.</strong> Want to hear more from Prognosis? Then listen to our podcast, which has explored superbugs, what we share when we share our medical data online, and more. Download it <a href="https://link.mail.bloombergbusiness.com/click/18816595.10615/aHR0cHM6Ly9pdHVuZXMuYXBwbGUuY29tL3VzL3BvZGNhc3QvcHJvZ25vc2lzL2lkMTQ0MDA1MTA4Nj9tdD0yP3NybmQ9cHJvZ25vc2lzLXBvZGNhc3Q/5daec32c52ba1e0621725115Bf397031c" itemprop="StoryLink" itemscope="itemscope" target="_blank" style="color: #000000">here</a> on Apple devices, and here on <a href="https://link.mail.bloombergbusiness.com/click/18816595.10615/aHR0cHM6Ly9wbGF5Lmdvb2dsZS5jb20vbXVzaWMvbGlzdGVuP3U9MCMvcHMvSWZidXdwNGZyamxtczR3eXducW51Ymh5cmNh/5daec32c52ba1e0621725115B3e4e2a86" itemprop="StoryLink" itemscope="itemscope" title="Android download link" style="color: #000000">Android</a>.</p>
<!--[if mso]>
<table width="550"><tr><td><img alt="" src="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iCN..I4Ldqog/v0/-1x-1.jpg" width="550" /></td></tr></table>
<div style="display:none">
<![endif]-->
<img alt="" src="https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iCN..I4Ldqog/v0/-1x-1.jpg" style="display: block; margin: auto; width: 100%">
<!--[if mso]>
</div>
<![endif]-->
<p style="font-family: Helvetica, Arial, sans-serif; margin: 1em 0">
<em>Got this newsletter forwarded to you? Sign up to get it every Thursday by <a href="https://link.mail.bloombergbusiness.com/click/18816595.10615/aHR0cDovL2xpbmsubWFpbC5ibG9vbWJlcmdidXNpbmVzcy5jb20vam9pbi80d20vcHJvZ25vc2lzLXNpZ251cD9zb3VyY2U9YXJ0aWNsZQ/5daec32c52ba1e0621725115C21e8517f" itemprop="StoryLink" itemscope="itemscope" style="color: #000000">clicking here</a>. <br><br>We want to hear from you. If you have feedback, questions or potential story ideas, reach out to me at <a href="mailto:tannett@bloomberg.net" itemprop="StoryLink" itemscope="itemscope" target="_blank" title="mailto:tannett@bloomberg.net" style="color: #000000">tannett@bloomberg.net</a></em>
</p>
</td>
</tr>
</table>
<table>
<tbody>
<tr>
<td height="20"> </td>
</tr>
<tr>
<td class="bbiz-wysiwyg-content tout-label"></td>
</tr>
<tr>
<td class="bbiz-wysiwyg-content tout-text"><p><strong>Like Bloomberg’s Prognosis?</strong> <em>Subscribe to Bloomberg.com. You’ll get our unmatched global news coverage and two premium daily newsletters, The Bloomberg Open and The Bloomberg Close, and much, much more. See our <a href="https://link.mail.bloombergbusiness.com/click/16070283.145331/aHR0cHM6Ly93d3cuYmxvb21iZXJnLmNvbS9zdWJzY3JpcHRpb25zP3V0bV9zb3VyY2U9bmV3c2xldHRlciZ1dG1fbWVkaXVtPWVtYWlsJnV0bV9jYW1wYWlnbj1ldmVuaW5nYnJpZWYmdXRtX3Rlcm09WVlNTURE/58091eb2b84a994a148b4b20Be63e5877">limited-time introductory offer</a>.</em></p>
<p><strong>Download the Bloomberg app:</strong> <em>It’s available <a href="https://link.mail.bloombergbusiness.com/click/16070283.145331/aHR0cDovL2xpbmsubWFpbC5ibG9vbWJlcmdidXNpbmVzcy5jb20vY2xpY2svMTAyNzYwMTcuMTgzNTczL2FIUjBjSE02THk5cGRIVnVaWE11WVhCd2JHVXVZMjl0TDJGd2NDOWhjSEJzWlMxemRHOXlaUzlwWkRJNE1UazBNVEE1Tno5d2REMDRPVFE1Sm1OMFBYSmxiR0YxYm1Ob1gyVnRZV2xzSm0xMFBUZy81NmZiZWNjMWU5YThhMjQxMDc4YjQ4YjFCOWU2MDcyNDE/58091eb2b84a994a148b4b20B42849805">for iOS</a> and <a href="https://link.mail.bloombergbusiness.com/click/16070283.145331/aHR0cDovL2xpbmsubWFpbC5ibG9vbWJlcmdidXNpbmVzcy5jb20vY2xpY2svMTAyNzYwMTcuMTgzNTczL2FIUjBjSE02THk5d2JHRjVMbWR2YjJkc1pTNWpiMjB2YzNSdmNtVXZZWEJ3Y3k5a1pYUmhhV3h6UDJsa1BXTnZiUzVpYkc5dmJXSmxjbWN1WVc1a2NtOXBaQzV3YkhWekpuSmxabVZ5Y21WeVBYVjBiVjl6YjNWeVkyVWxNMFJsYldGcGJDVXlOblYwYlY5allXMXdZV2xuYmlVelJISmxiR0YxYm1Oby81NmZiZWNjMWU5YThhMjQxMDc4YjQ4YjFCNDMwMDQ2ODA/58091eb2b84a994a148b4b20Bc061af45">Android</a>.</em></p>
<p><em>Before it's here, it's on the Bloomberg Terminal. Find out more about how the Terminal delivers information and analysis that financial professionals can't find anywhere else. <a href="https://link.mail.bloombergbusiness.com/click/15638356.78421/aHR0cHM6Ly93d3cuYmxvb21iZXJnLmNvbS9wcm9mZXNzaW9uYWwvc29sdXRpb24vYmxvb21iZXJnLXRlcm1pbmFsLw/55088ec43b35d034698d38aeBe3d4e6ab">Learn more</a>.</em></p></td>
</tr>
<tr>
<td height="20"> </td>
</tr>
</tbody>
</table>
<table id="footer" width="100%" align="center" border="0" cellpadding="0" cellspacing="0">
<tr>
<td align="center" style="border-collapse: collapse; mso-table-lspace: 0pt; mso-table-rspace: 0pt; font-size: 13px; font-family: Helvetica, Arial, sans-serif; color: #666666; padding-bottom: 10px">You received this message because you are subscribed to Bloomberg's Prognosis newsletter.</td>
</tr>
<tr>
<td align="center" style="border-collapse: collapse; mso-table-lspace: 0pt; mso-table-rspace: 0pt; font-size: 13px; font-family: Helvetica, Arial, sans-serif; color: #666666"><a href="https://link.mail.bloombergbusiness.com/click/18816595.10615/aHR0cHM6Ly9sb2dpbi5ibG9vbWJlcmcuY29tL25ld3NsZXR0ZXJzP3NvdXJjZT1uZXdzbGV0dGVyX3Vuc3ViJmVtYWlsPXB1Ymxpc2gtYmxvb21iZXJnJTQwZW1tYXJlcy5uZXQmaGFzaD1kMTYxYmU4YmU0ZTUyNzFlMGMwZTMzMThiYWVhNjg1Yg/5daec32c52ba1e0621725115B61b9e4f7" style="color: #666666; text-decoration: none" alias="  | <a href="https://link.mail.bloombergbusiness.com/click/18816595.10615/aHR0cDovL2Jsb29tYmVyZy5jb20/5daec32c52ba1e0621725115B9bb7b86b" style="color: #666666; text-decoration: none" target="_blank">Bloomberg.com</a> | <a href="https://link.mail.bloombergbusiness.com/click/18816595.10615/aHR0cDovL3d3dy5ibG9vbWJlcmcuY29tL2ZlZWRiYWNrP2FsY21waWQ9bW9zdHBvcA/5daec32c52ba1e0621725115Bc524700c" style="color: #666666; text-decoration: none" target="_blank">Contact Us</a></td>
</tr>
<tr>
<td height="20" align="center" style="border-collapse: collapse; mso-table-lspace: 0pt; mso-table-rspace: 0pt; font-size: 13px; font-family: Helvetica, Arial, sans-serif; color: #666666">Bloomberg L.P. 731 Lexington, New York, NY, 10022</td>
</tr>
</table>
<!--[if mso]>
</td></tr>
</table>
</center>
<![endif]-->
</td>
</tr>
</table><custom name="opencounter" type="tracking"><a href=""><img src="https://link.mail.bloombergbusiness.com/img/5daec32c52ba1e0621725115b7az7.86v/5438f777.gif" alt="" border="0"></a></custom>